msdc-0160
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00760578)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mitoglitazone
- mitoglitazone
- mitoglitazone
- msdc-0160
- msdc-0160
- msdc-0160
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01374438 | Phase 2 | Jul 1, 2011 | Metabolic Solutions Inc., Rush University |
| NCT01103414 | Phase 2 | Sep 1, 2010 | Metabolic Solutions Inc. |
| NCT00760578 | Phase 2 | Sep 1, 2008 | Metabolic Solutions Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Metabolic Solutions Inc. | For profit | 3 | 3 | 1 | 2008 |
| Rush University | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1